144 related articles for article (PubMed ID: 35860797)
41. Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer.
Liu C; Pan Z; Chen Q; Chen Z; Liu W; Wu L; Jiang M; Lin W; Zhang Y; Lin W; Zhou R; Zhao L
J Exp Clin Cancer Res; 2021 Sep; 40(1):297. PubMed ID: 34551797
[TBL] [Abstract][Full Text] [Related]
42. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
43. Melatonin Induces Autophagy via Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress Pathway in Colorectal Cancer Cells.
Chok KC; Koh RY; Ng MG; Ng PY; Chye SM
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443626
[TBL] [Abstract][Full Text] [Related]
44. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
[TBL] [Abstract][Full Text] [Related]
45. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Stefani C; Miricescu D; Stanescu-Spinu II; Nica RI; Greabu M; Totan AR; Jinga M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638601
[TBL] [Abstract][Full Text] [Related]
46. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
47. Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/MTOR pathway.
Li N; Zhang Z; Jiang G; Sun H; Yu D
Front Biosci (Landmark Ed); 2019 Jan; 24(2):303-312. PubMed ID: 30468657
[TBL] [Abstract][Full Text] [Related]
48. A novel protective role for microRNA-3135b in Golgi apparatus fragmentation induced by chemotherapy via GOLPH3/AKT1/mTOR axis in colorectal cancer cells.
Núñez-Olvera SI; Chávez-Munguía B; Del Rocío Terrones-Gurrola MC; Marchat LA; Puente-Rivera J; Ruíz-García E; Campos-Parra AD; Vázquez-Calzada C; Lizárraga-Verdugo ER; Ramos-Payán R; Salinas-Vera YM; López-Camarillo C
Sci Rep; 2020 Jun; 10(1):10555. PubMed ID: 32601379
[TBL] [Abstract][Full Text] [Related]
49. MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway.
Su W; Feng B; Hu L; Guo X; Yu M
BMC Cancer; 2022 Jun; 22(1):602. PubMed ID: 35655161
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
Qin A; Qian W
Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
[TBL] [Abstract][Full Text] [Related]
51. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.
Wei R; Yang Q; Han B; Li Y; Yao K; Yang X; Chen Z; Yang S; Zhou J; Li M; Yu H; Yu M; Cui Q
Oncotarget; 2017 Mar; 8(10):16633-16641. PubMed ID: 28186962
[TBL] [Abstract][Full Text] [Related]
52. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD
Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121
[TBL] [Abstract][Full Text] [Related]
53. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Xu M; Wang J; Li H; Zhang Z; Cheng Z
Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
[TBL] [Abstract][Full Text] [Related]
54. The effect of JAK2 knockout on inhibition of liver tumor growth by inducing apoptosis, autophagy and anti-proliferation via STATs and PI3K/AKT signaling pathways.
Xu Y; Lv SX
Biomed Pharmacother; 2016 Dec; 84():1202-1212. PubMed ID: 27788478
[TBL] [Abstract][Full Text] [Related]
55. Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling.
He SQ; Gao M; Fu YF; Zhang YN
Int J Clin Exp Pathol; 2015; 8(5):5175-81. PubMed ID: 26191214
[TBL] [Abstract][Full Text] [Related]
56. Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1.
Alqurashi N; Hashimi SM; Alowaidi F; Ivanovski S; Wei MQ
Oncol Rep; 2018 Aug; 40(2):1083-1092. PubMed ID: 29845289
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of STK25 promotes autophagy via the Janus kinase 2/signal transducer and activator of transcription 3 pathway in colorectal cancer.
Chen J; Gao P; Peng L; Liu T; Wu F; Xu K; Chen L; Tan F; Xing P; Wang Z; Di J; Jiang B; Su X
Mol Carcinog; 2022 Jun; 61(6):572-586. PubMed ID: 35349179
[TBL] [Abstract][Full Text] [Related]
58. xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade.
Tang B; Zhu J; Liu F; Ding J; Wang Y; Fang S; Zheng L; Qiu R; Chen M; Shu G; Xu M; Lu C; Zhao Z; Yang Y; Ji J
Cell Death Dis; 2022 Apr; 13(4):373. PubMed ID: 35440604
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling.
Xiong H; Chen ZF; Liang QC; Du W; Chen HM; Su WY; Chen GQ; Han ZG; Fang JY
J Cell Mol Med; 2009 Sep; 13(9B):3668-79. PubMed ID: 20196786
[TBL] [Abstract][Full Text] [Related]
60. [IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].
Liu C; Xie C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):870-5. PubMed ID: 27363263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
